company background image
8049 logo

Jilin Province Huinan Changlong Bio-pharmacy SEHK:8049 Stock Report

Last Price

HK$1.28

Market Cap

HK$717.1m

7D

-1.5%

1Y

-5.9%

Updated

24 Jul, 2024

Data

Company Financials

Jilin Province Huinan Changlong Bio-pharmacy Company Limited

SEHK:8049 Stock Report

Market Cap: HK$717.1m

8049 Stock Overview

Engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People’s Republic of China.

8049 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends2/6

Jilin Province Huinan Changlong Bio-pharmacy Company Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Jilin Province Huinan Changlong Bio-pharmacy
Historical stock prices
Current Share PriceHK$1.28
52 Week HighHK$1.95
52 Week LowHK$1.13
Beta0.076
11 Month Change-3.03%
3 Month Change-30.81%
1 Year Change-5.88%
33 Year Change25.49%
5 Year Change29.29%
Change since IPO-7.91%

Recent News & Updates

Here's Why Shareholders May Consider Paying Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) CEO A Little More

May 21
Here's Why Shareholders May Consider Paying Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) CEO A Little More

Recent updates

Here's Why Shareholders May Consider Paying Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) CEO A Little More

May 21
Here's Why Shareholders May Consider Paying Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) CEO A Little More

There May Be Reason For Hope In Jilin Province Huinan Changlong Bio-pharmacy's (HKG:8049) Disappointing Earnings

Apr 04
There May Be Reason For Hope In Jilin Province Huinan Changlong Bio-pharmacy's (HKG:8049) Disappointing Earnings

With EPS Growth And More, Jilin Province Huinan Changlong Bio-pharmacy (HKG:8049) Makes An Interesting Case

Mar 26
With EPS Growth And More, Jilin Province Huinan Changlong Bio-pharmacy (HKG:8049) Makes An Interesting Case

Investors Don't See Light At End Of Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) Tunnel

Dec 27
Investors Don't See Light At End Of Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) Tunnel

With EPS Growth And More, Jilin Province Huinan Changlong Bio-pharmacy (HKG:8049) Makes An Interesting Case

Jul 12
With EPS Growth And More, Jilin Province Huinan Changlong Bio-pharmacy (HKG:8049) Makes An Interesting Case

It's Unlikely That Shareholders Will Increase Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) Compensation By Much This Year

Jun 05
It's Unlikely That Shareholders Will Increase Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) Compensation By Much This Year

How Is Jilin Province Huinan Changlong Bio-pharmacy's (HKG:8049) CEO Paid Relative To Peers?

Nov 26
How Is Jilin Province Huinan Changlong Bio-pharmacy's (HKG:8049) CEO Paid Relative To Peers?

Shareholder Returns

8049HK PharmaceuticalsHK Market
7D-1.5%0.8%-2.4%
1Y-5.9%-6.9%-2.8%

Return vs Industry: 8049 exceeded the Hong Kong Pharmaceuticals industry which returned -6.9% over the past year.

Return vs Market: 8049 underperformed the Hong Kong Market which returned -2.8% over the past year.

Price Volatility

Is 8049's price volatile compared to industry and market?
8049 volatility
8049 Average Weekly Movement7.0%
Pharmaceuticals Industry Average Movement5.0%
Market Average Movement6.8%
10% most volatile stocks in HK Market14.4%
10% least volatile stocks in HK Market3.7%

Stable Share Price: 8049's share price has been volatile over the past 3 months.

Volatility Over Time: 8049's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1989848Hong Zhangwww.jlchanglong.com

Jilin Province Huinan Changlong Bio-pharmacy Company Limited engages in the manufacture and distribution of Chinese medicines and pharmaceutical products in the People’s Republic of China. It offers Edaravone injection, compound brain comfort capsules, haikun kidney hi capsules, cefpirome sulfate for injections, Cefpiramide for injections, anti-bone hyperplasia tablets, Lysine glucosa tablets, prostate laurel yellow tablets, tranquility tablets, pharyngitis tablets, and low back pain capsules. The company markets its products under the Changlong and Qing Tong brands.

Jilin Province Huinan Changlong Bio-pharmacy Company Limited Fundamentals Summary

How do Jilin Province Huinan Changlong Bio-pharmacy's earnings and revenue compare to its market cap?
8049 fundamental statistics
Market capHK$717.12m
Earnings (TTM)HK$159.05m
Revenue (TTM)HK$903.11m

4.5x

P/E Ratio

0.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
8049 income statement (TTM)
RevenueCN¥841.55m
Cost of RevenueCN¥257.50m
Gross ProfitCN¥584.05m
Other ExpensesCN¥435.84m
EarningsCN¥148.21m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.26
Gross Margin69.40%
Net Profit Margin17.61%
Debt/Equity Ratio5.4%

How did 8049 perform over the long term?

See historical performance and comparison

Dividends

41.9%

Current Dividend Yield

n/a

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.